Position in ACAD
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$3,115,598
+$195,689 QoQ
Shares Held
139,964
+28.0% QoQ
Ownership
0.082%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2022
7 quarters on record
Voting authority
Sole 64.34797519362122.ToString("F0")%
Shared 0.ToString("F0")%
None 35.65202480637878.ToString("F0")%
Common Shares in ACAD Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026MARTINGALE ASSET MANAGEMENT L P holds $113,855,320 across 56 Biotechnology names. ACAD ranks #8 (2.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
44,750 | $19,982,665 | |
| 2 | INCY |
Incyte Corp
|
164,646 | $15,496,481 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
16,861 | $13,027,483 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
46,721 | $8,832,605 | |
| 5 | LGND |
Ligand Pharmaceuticals Inc
|
17,762 | $3,546,183 | |
| 6 | CPRX |
Catalyst Pharmaceuticals, Inc.
|
139,535 | $3,454,886 | |
| 7 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
10,114 | $3,346,419 | |
| 8 | ACAD |
Acadia Pharmaceuticals Inc
This page
|
139,964 | $3,115,598 |
All Filings in ACAD
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,115,598 | 139,964 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $2,919,909 | 109,319 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $2,140,999 | 100,328 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $1,494,369 | 69,280 | Shares | Sole | 2025-08-11 | |
| 2023-06-30 | $248,313 | 10,368 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $195,201 | 10,372 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $165,154 | 10,374 | Shares | Sole | 2023-02-13 | |
| No filing history on record for this holder in this stock. | ||||||